This is an old revision of this page, as edited by Anypodetos talk | contribs ) at 13:23, 16 December 2011 (Disambig Humanize , replaced: humanized monoclonal antibody → humanized monoclonal antibody using AWB ). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision .
Revision as of 13:23, 16 December 2011 by Anypodetos talk | contribs ) (Disambig Humanize , replaced: humanized monoclonal antibody → humanized monoclonal antibody using AWB )(diff ) ← Previous revision | Latest revision (diff ) | Newer revision → (diff )
Pharmaceutical compound
Urtoxazumab is a humanized monoclonal antibody against diarrhoea caused by Escherichia coli O121 . The drug is designed to bind to a toxin of this bacterium, so that it can be more easily broken down and eliminated from the body.
References
International Nonproprietary Names for Pharmaceutical Substances (INN) , World Health Organization .
López, EL; Contrini, MM; Glatstein, E; González Ayala, S; Santoro, R; Allende, D; Ezcurra, G; Teplitz, E; Koyama, T (2009). "Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody Against Shiga-Like Toxin 2 in Healthy Adults and Pediatric STEC- Infected Patients" . Antimicrobial agents and chemotherapy . 54 (1): 239–243. doi :10.1128/AAC.00343-09 . PMC 2798559 . PMID 19822704 .
Categories :
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
**DISCLAIMER** We are not affiliated with Wikipedia, and Cloudflare.
The information presented on this site is for general informational purposes only and does not constitute medical advice.
You should always have a personal consultation with a healthcare professional before making changes to your diet, medication, or exercise routine.
AI helps with the correspondence in our chat.
We participate in an affiliate program. If you buy something through a link, we may earn a commission 💕
↑
